Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Herbalife Nutrition Ltd (HLF) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance

Herbalife Nutrition LtdTrade
Kymera Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Herbalife Nutrition Ltd vs Kymera Therapeutics Inc. Common Stock — how do they compare? Herbalife Nutrition Ltd trades at $13.76 (market cap $1.49B), while Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 6× Herbalife Nutrition Ltd's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Herbalife Nutrition Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Herbalife Nutrition Ltd for 43 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.

HLFKYMR
Market Cap
$1.49B$8.87B
Volume
1,708,975779,107
Sector
Consumer StaplesHealth
52-Week High
$19.96$127.31
52-Week Low
$7.75$55.80
Typical Hold Time
43 Days0 Days
Enterprise Value
$3.32B$8.26B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Herbalife Nutrition Ltd

HLF trades at $14.19, up 4.26% today, with a bullish technical signal and strong analyst consensus. The stock shows attractive valuation with a P/E of 9.11 and P/S of 0.29, supported by a gross profit margin of 77.7%. Recent news includes a $250 million share repurchase program and a planned CEO transition in October 2026. Cash flow trends indicate improving operational cash generation, with 2026 projected net cash flow turning positive at $50 million.

The outlook for HLF is positive, with a consensus price target of $19.00 implying 34% upside. Risks include negative shareholder equity, high debt levels, and mixed quarterly earnings performance. Revenue stability and margin expansion efforts provide a foundation for growth, but investor caution is warranted due to ongoing leadership changes and competitive pressures in the wellness sector.

Kymera Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HLF
83% Buy17% Sell
Avg holding period · 43 Days
KYMR
100% Buy0% Sell
Avg holding period · 0 Days

About Herbalife Nutrition Ltd

Herbalife Nutrition Ltd is an international nutrition company.

Read more on HLF →

About Kymera Therapeutics Inc. Common Stock

Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.

Read more on KYMR →